Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Edaravone (MCI-186)(MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 43.00 | |
5 g | In stock | $ 52.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Edaravone (MCI-186)(MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction. |
Cell Research | Cell viability is quantified by MTT assay and trypan blue staining. MTT (5?mg/mL, 20?μL) is added to each well and incubated for 4?h at 37°C after the drug treatments. The medium is removed and the cell pellet is dissolved in DMSO. Then, the optical density (OD) values are measured at 570?nm using an ELISA reader. |
Synonyms | MCI-186 |
Molecular Weight | 174.2 |
Formula | C10H10N2O |
CAS No. | 89-25-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 17.4 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Edaravone 89-25-8 Apoptosis oxidation-reduction Proteases/Proteasome MMP Free radical scavengers Inhibitor Matrix metalloproteinases MCI 186 MCI-186 inhibit MCI186 inhibitor